Janus Henderson Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $162M | Buy |
209,248
+3,576
| +2% | +$2.74M | 0.08% | 222 |
|
|
2025
Q4 | $159M | Buy |
205,672
+131,929
| +179% | +$89.6M | 0.07% | 219 |
|
|
2025
Q3 | $41.5M | Buy |
73,743
+60,655
| +463% | +$34.3M | 0.02% | 451 |
|
|
2025
Q2 | $6.87M | Sell |
13,088
-465
| -3% | -$260K | ﹤0.01% | 813 |
|
|
2025
Q1 | $8.64M | Buy |
13,553
+80
| +0.6% | +$55K | ﹤0.01% | 740 |
|
|
2024
Q4 | $9.6M | Sell |
13,473
-84,661
| -86% | -$71M | ﹤0.01% | 739 |
|
|
2024
Q3 | $103M | Sell |
98,134
-2,290
| -2% | -$2.55M | 0.05% | 274 |
|
|
2024
Q2 | $106M | Sell |
100,424
-3,568
| -3% | -$3.46M | 0.06% | 255 |
|
|
2024
Q1 | $100M | Sell |
103,992
-8,837
| -8% | -$8.4M | 0.05% | 265 |
|
|
2023
Q4 | $99.1M | Sell |
112,829
-9,584
| -8% | -$7.89M | 0.06% | 253 |
|
|
2023
Q3 | $101M | Buy |
122,413
+35,120
| +40% | +$27.6M | 0.07% | 245 |
|
|
2023
Q2 | $62.7M | Sell |
87,293
-109,778
| -56% | -$84.6M | 0.04% | 347 |
|
|
2023
Q1 | $162M | Sell |
197,071
-49,951
| -20% | -$37.7M | 0.11% | 184 |
|
|
2022
Q4 | $178M | Sell |
247,022
-323,524
| -57% | -$239M | 0.13% | 175 |
|
|
2022
Q3 | $393M | Buy |
570,546
+415,027
| +267% | +$261M | 0.15% | 157 |
|
|
2022
Q2 | $91.9M | Sell |
155,519
-13,183
| -8% | -$8.57M | 0.06% | 266 |
|
|
2022
Q1 | $118M | Sell |
168,702
-10,276
| -6% | -$6.5M | 0.06% | 291 |
|
|
2021
Q4 | $113M | Sell |
178,978
-18,668
| -9% | -$11.5M | 0.05% | 336 |
|
|
2021
Q3 | $120M | Sell |
197,646
-10,300
| -5% | -$6.39M | 0.05% | 331 |
|
|
2021
Q2 | $116M | Sell |
207,946
-26,381
| -11% | -$13.4M | 0.05% | 347 |
|
|
2021
Q1 | $111M | Sell |
234,327
-147,496
| -39% | -$71.8M | 0.05% | 342 |
|
|
2020
Q4 | $184M | Buy |
381,823
+40,236
| +12% | +$21.7M | 0.09% | 239 |
|
|
2020
Q3 | $191M | Buy |
341,587
+46,572
| +16% | +$28.2M | 0.1% | 211 |
|
|
2020
Q2 | $184M | Buy |
295,015
+257,084
| +678% | +$146M | 0.1% | 206 |
|
|
2020
Q1 | $18.5M | Buy |
37,931
+9,363
| +33% | +$3.86M | 0.01% | 689 |
|
|
2019
Q4 | $10.7M | Sell |
28,568
-203,166
| -88% | -$68.4M | 0.01% | 945 |
|
|
2019
Q3 | $64.3M | Sell |
231,734
-66,398
| -22% | -$19.6M | 0.03% | 501 |
|
|
2019
Q2 | $93.3M | Sell |
298,132
-132,020
| -31% | -$44M | 0.05% | 396 |
|
|
2019
Q1 | $177M | Sell |
430,152
-505,998
| -54% | -$208M | 0.1% | 240 |
|
|
2018
Q4 | $350M | Sell |
936,150
-605,891
| -39% | -$222M | 0.22% | 112 |
|
|
2018
Q3 | $623M | Sell |
1,542,041
-260,699
| -14% | -$99.2M | 0.33% | 66 |
|
|
2018
Q2 | $622M | Buy |
1,802,740
+203,306
| +13% | +$63.6M | 0.35% | 63 |
|
|
2018
Q1 | $551M | Sell |
1,599,434
-74,406
| -4% | -$25.9M | 0.32% | 74 |
|
|
2017
Q4 | $629M | Buy |
1,673,840
+128,510
| +8% | +$52M | 0.38% | 54 |
|
|
2017
Q3 | $691M | Sell |
1,545,330
-17,640
| -1% | -$8.39M | 0.44% | 41 |
|
|
2017
Q2 | $768M | Buy |
1,562,970
+1,552,948
| +15,495% | +$680M | 0.52% | 29 |
|
|
2017
Q1 | $3.88M | Buy |
10,022
+200
| +2% | +$74.1K | 0.03% | 394 |
|
|
2016
Q4 | $3.61M | Buy |
9,822
+402
| +4% | +$153K | 0.03% | 400 |
|
|
2016
Q3 | $3.79M | Hold |
9,420
| – | – | 0.03% | 375 |
|
|
2016
Q2 | $3.29M | Hold |
9,420
| – | – | 0.03% | 385 |
|
|
2016
Q1 | $3.4M | Sell |
9,420
-18,879
| -67% | -$7.78M | 0.03% | 391 |
|
|
2015
Q4 | $15.4M | Buy |
28,299
+4,129
| +17% | +$2.24M | 0.12% | 194 |
|
|
2015
Q3 | $11.2M | Buy |
24,170
+14,358
| +146% | +$7.71M | 0.1% | 228 |
|
|
2015
Q2 | $5.01M | Sell |
9,812
-1,394
| -12% | -$680K | 0.04% | 361 |
|
|
2015
Q1 | $5.06M | Hold |
11,206
| – | – | 0.04% | 362 |
|
|
2014
Q4 | $4.6M | Hold |
11,206
| – | – | 0.03% | 378 |
|
|
2014
Q3 | $4.04M | Hold |
11,206
| – | – | 0.04% | 310 |
|
|
2014
Q2 | $3.17M | Hold |
11,206
| – | – | 0.03% | 345 |
|
|
2014
Q1 | $3.37M | Buy |
11,206
+2,150
| +24% | +$662K | 0.03% | 337 |
|
|
2013
Q4 | $2.49M | Hold |
9,056
| – | – | 0.03% | 363 |
|
|
2013
Q3 | $2.83M | Buy |
9,056
+808
| +10% | +$213K | 0.03% | 336 |
|
|
2013
Q2 | $1.9M | Buy |
+8,248
| New | +$1.92M | 0.02% | 387 |
|
Other funds holding REGN
VCM
N
Janus Henderson Group's REGN Position: Q1 2026 in Review
Janus Henderson Group increased its Regeneron Pharmaceuticals (REGN) stake by 1.7% in Q1 2026, buying an estimated $2.74M and bringing the position to 209,248 shares worth $162M. The position accounts for 0.08% of the portfolio, ranked #222.
Janus Henderson Group first reported a position in REGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $768M in Q2 2017. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- Janus Henderson Group held 209,248 shares of Regeneron Pharmaceuticals worth $162M as of Q1 2026.
- Janus Henderson Group bought 3,576 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $2.74M.
- Regeneron Pharmaceuticals made up 0.08% of Janus Henderson Group's portfolio in Q1 2026, its #222 holding.
- Janus Henderson Group first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Janus Henderson Group's Regeneron Pharmaceuticals position peaked at $768M in Q2 2017.
- 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.